Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

Asian shares were mostly higher Friday ahead of an update on the U.S. job market that will offer insights into how the economy is faring. U.S. futures edged higher and oil prices fell. Tokyo's Nikkei ...

This was the stock's second consecutive day of losses.

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

The company is willing to back new limits on lucrative payments insurers can gain from diagnoses recorded by nurse ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

Humana Inc. closed 43.21% below its 52-week high of $406.46, which the company reached on July 18th.

U.S. equities were slightly higher at midday as a new report on private sector hiring missed estimates, sending bond yields down.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory ...